$60,000 of EXELON CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Climate, Energy Related Issues and Tax"
You can find more data on corporate lobbying on Quiver Quantitative.
EXC Congressional Stock Trading
Members of Congress have traded $EXC stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EXC stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $50,000 on 08/28.
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
EXC Hedge Fund Activity
We have seen 594 institutional investors add shares of EXC stock to their portfolio, and 461 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GQG PARTNERS LLC added 25,213,351 shares (+1029.7%) to their portfolio in Q2 2025, for an estimated $1,094,763,700
- PRICE T ROWE ASSOCIATES INC /MD/ removed 11,655,576 shares (-72.6%) from their portfolio in Q2 2025, for an estimated $506,085,109
- LAZARD ASSET MANAGEMENT LLC removed 5,351,820 shares (-24.1%) from their portfolio in Q2 2025, for an estimated $232,376,024
- VOYA INVESTMENT MANAGEMENT LLC removed 3,773,612 shares (-87.4%) from their portfolio in Q2 2025, for an estimated $163,850,233
- CITADEL ADVISORS LLC added 3,643,927 shares (+313.1%) to their portfolio in Q2 2025, for an estimated $158,219,310
- CANADA PENSION PLAN INVESTMENT BOARD added 3,476,942 shares (+164.3%) to their portfolio in Q2 2025, for an estimated $150,968,821
- MILLENNIUM MANAGEMENT LLC removed 3,107,716 shares (-95.3%) from their portfolio in Q2 2025, for an estimated $134,937,028
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EXC Analyst Ratings
Wall Street analysts have issued reports on $EXC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Underweight" rating on 07/16/2025
- Guggenheim issued a "Buy" rating on 05/02/2025
- Mizuho issued a "Outperform" rating on 04/28/2025
- BMO Capital issued a "Outperform" rating on 04/28/2025
To track analyst ratings and price targets for EXC, check out Quiver Quantitative's $EXC forecast page.
EXC Price Targets
Multiple analysts have issued price targets for $EXC recently. We have seen 9 analysts offer price targets for $EXC in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- David Arcaro from Morgan Stanley set a target price of $49.0 on 09/25/2025
- Jackson Ader from Keybanc set a target price of $37.0 on 07/16/2025
- Daniel Ford from UBS set a target price of $48.0 on 07/11/2025
- Neil Kalton from Wells Fargo set a target price of $50.0 on 05/02/2025
- Shahriar Pourreza from Guggenheim set a target price of $50.0 on 05/02/2025
- Durgesh Chopra from Evercore ISI Group set a target price of $51.0 on 05/02/2025
- Paul Fremont from Mizuho set a target price of $50.0 on 04/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
